Additionally, South America exhibits the maximum prevalence of EBV at 30%, while Africa has the lowest prevalence at 0%, as determined by the examination of various geographical regions.31 In a separate study, EBV DNA was detected in 60% of tumor samples, and 13.3% of cancer patients had EBV DNA detected in both the tumor and their NAT.32 This evidence concerns the gene BRD2 and cancer.